BioCryst Pharmaceuticals (BCRX)
(Delayed Data from NSDQ)
$4.21 USD
-0.17 (-3.88%)
Updated Apr 24, 2024 04:00 PM ET
After-Market: $4.22 +0.01 (0.24%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth F Momentum C VGM
Detailed Estimates
EPS Estimates
Earnings Date | *BMO5/6/24 |
---|---|
Current Quarter | -0.23 |
EPS Last Quarter | -0.28 |
Last EPS Surprise | -16.67% |
ABR | 1.50 |
Earnings ESP
|
11.11% |
---|---|
Current Year | -0.69 |
Next Year | -0.25 |
EPS (TTM) | -0.99 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 85.60M | 96.97M | 397.95M | 493.47M |
# of Estimates | 5 | 5 | 5 | 5 |
High Estimate | 87.41M | 101.53M | 403.01M | 510.06M |
Low Estimate | 83.50M | 94.63M | 393.51M | 479.06M |
Year ago Sales | 68.78M | 82.49M | 331.41M | 397.95M |
Year over Year Growth Est. | 24.45% | 17.55% | 20.08% | 24.01% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.23 | -0.16 | -0.69 | -0.25 |
# of Estimates | 6 | 5 | 7 | 7 |
Most Recent Consensus | -0.19 | -0.16 | -0.63 | -0.11 |
High Estimate | -0.19 | -0.14 | -0.56 | 0.20 |
Low Estimate | -0.28 | -0.19 | -0.84 | -0.68 |
Year ago EPS | -0.28 | -0.24 | -1.00 | -0.69 |
Year over Year Growth Est. | 17.86% | 33.33% | 31.00% | 63.77% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 2 | 2 | 3 | 2 |
Down Last 7 Days | 1 | 1 | 1 | 0 |
Down Last 30 Days | 1 | 1 | 2 | 0 |
Down Last 60 Days | 1 | 1 | 4 | 3 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.23 | -0.16 | -0.69 | -0.25 |
7 Days Ago | -0.22 | -0.16 | -0.68 | -0.25 |
30 Days Ago | -0.23 | -0.16 | -0.62 | -0.25 |
60 Days Ago | -0.25 | -0.18 | -0.67 | -0.32 |
90 Days Ago | -0.25 | -0.18 | -0.67 | -0.32 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.20 | -0.16 | -0.62 | -0.25 |
Zacks Consensus Estimate | -0.23 | -0.16 | -0.69 | -0.25 |
Earnings ESP | 11.11% | 1.24% | 9.77% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.28 | -0.19 | -0.24 | -0.28 | NA |
Estimate | -0.24 | -0.25 | -0.25 | -0.30 | NA |
Difference | -0.04 | 0.06 | 0.01 | 0.02 | 0.01 |
Surprise | -16.67% | 24.00% | 4.00% | 6.67% | 4.50% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more